CG Oncology Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Annual meetings show how shareholders exercise voting power on company decisions and leadership.
Leadership changes affect who runs the company and can signal strategic shifts.
New leadership appointments show how companies adapt their management structure.
Quarterly earnings show if a company is making money and growing its business.
New CFOs manage money and accounting, critical roles for company financial health.
Annual results show total company performance and help investors understand yearly progress.
Full-year financial reports reveal company health and guide investor expectations ahead.
Stocky reads CG Oncology Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
CG Oncology Inc.'s most recent tracked filing was a 8-K on 8 Jun 2026: Stockholders vote at 2026 annual meeting June 4.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.